GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus (GENIAL)
Primary Purpose
Systemic Lupus Erythematosus (SLE)
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Blood sampling
Sponsored by
About this trial
This is an interventional other trial for Systemic Lupus Erythematosus (SLE) focused on measuring Systemic lupus erythematosus, genetic, immunological, pediatric, mutation, lupus
Eligibility Criteria
Inclusion Criteria:
Male or female subject, major or minor of any age with SLE (defined according to the ACR criteria)
- Onset pediatric (<18 years) OR
- Syndromic Lupus (associated with growth retardation, neurological deficit not related to lupus, frostbite, lymphoproliferation, the kidney malformations, heart, lung, brain calcifications) OR
- Lupus in context with familial consanguinity OR
- Familial cases (2 cases of SLE related first degree relative) OR related topic of the first degree to a lupus patient participant (if family lupus or related parents) OR
- mother/father's lupus patient (in cas of simplex lupus)
- A person or beneficiary entitled to a social security scheme or similar
- Informed consent signed by the person (or parent / holding parental authority for minors)
Exclusion Criteria:
- none
Sites / Locations
- Service d'hématologie / oncologie pédiatrique - CHU
- Néphrologie Pédiatrique - CHU Besançon
- Hôpital Femme Mère Enfant
- Service de Néphrologie Pédiatrique
- Service de pédiatrie - CHU Fort de France
- Service de Néphrologie et Rhumatologie Pédiatrique
- Service de Rhumatologie Pédiatrique - Hôpital de Bicêtre
- Service de médecine interne - Centre de référence des maladies rares
- Service de néphrologie, endocrinologie, maladie métabolique et hématologie bénigne pédiatriques - Hôpital Jeanne de Flandre
- édiatrie générale, urgences et maladies infectieuses, Hôpital Salengro
- Service de Néphrologie - Hôpital Edouard Herriot
- Centre de néphrologie et de transplantation rénale - Hôpital de la conception
- Service de médecine infantile- Hôpital Nord
- Service de médecine interne - Hôpitaux privés de Metz
- ervice d'urgence et post-urgences pédiatriques - CHU Arnaud de Villeneuve
- Service médecine infantile 2
- Service de néphrologie pédiatrique - CHU de Nantes
- Service d'immunologie et rhumatologie pédiatrique - Centre de référence de maladies rhumatologiques et inflammatoires rares en pédiatrie-Hôpital Necker-Enfants malades
- Service de médecine interne - Hôpital Saint Antoine
- Service de pédiatrie générale - Hôpital Robert-Debré
- Médecine Interne Adulte - Centre Hospitalier Lyon Sud
- Service de Rhumatologie - Centre Hospitalier Lyon Sud
- Service pédiatrie grands enfants-adolescents - CHU Hôpital Sud
- Hôpital Nord
- Service de Pédiatrie Générale - CHU Réunion
- Service de néphrologie - médecine interne - Hypertension pédiatrique - Hôpital des enfants
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Blood sampling
Arm Description
Outcomes
Primary Outcome Measures
New genes identification
Description: Identification of genetic mutations in the following genes: TREX1, SAMHD1, ACP5, DNAse1, DNAse1L3, or in new lupus genes.
Secondary Outcome Measures
Immunological genotype and clinical abnormalities correlation
Correlate genotype to immunological (interferon alpha, …) and clinical abnormalities (microcrania, growth retardation, …)
Full Information
NCT ID
NCT01992666
First Posted
November 8, 2013
Last Updated
July 25, 2018
Sponsor
Hospices Civils de Lyon
1. Study Identification
Unique Protocol Identification Number
NCT01992666
Brief Title
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
Acronym
GENIAL
Official Title
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
Study Type
Interventional
2. Study Status
Record Verification Date
July 2018
Overall Recruitment Status
Completed
Study Start Date
October 2013 (undefined)
Primary Completion Date
October 2016 (Actual)
Study Completion Date
October 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hospices Civils de Lyon
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease for which the aetiology includes genet-ic and environmental factors. It is rare in children as compared to adults. The severity may be related to greater involvement of genetic factors in children. The impact of genetics in the development of SLE is important, and the risk of recurrence in siblings evaluated by lambda S ratio is 30 in SLE, while it is 15 for type-1 diabetes and 8 rheumatoid arthritis, thereby indicating high impact of genetics in SLE.
Recently, the group of Professor Yanick Crow in Manchester and other teams has identified new forms of lupus Mendelian genetics. The TREX1 and genes involved in the SAMHD1 frostbite lupus.
Nearly 2 % of all adult subjects with SLE have a heterozygous mutation in the TREX1 gene, which therefore represents the first genetic cause of SLE. The team of Professor Crow also identified the ACP5 gene that is responsible for SLE associated with Spondylo-epiphyseal enchondro-epiphyseal dysplasia (syndromic lupus). Other groups have identified mutations in two genes encoding a DNAse (DNAse1 and DNAse1L3) responsible for familial monogenic forms of SLE. These new genes SLE were identified through research of germ-line mutations in cases of lupus syndromic or family. In collaboration with Professor Crow, we are currently undergoing characterization of a novel gene of SLE in a family and we have identified a second locus identified in another family. The identification of these genes provides a better understanding of the mechanisms regulating immune tolerance in humans. The frequency of these genetic forms is not known. There is very little data on the immunological phenotype of these patients.
This is a clinical study to investigate the genetic and immunological abnormalities associated with pediatric SLE. The aim are to:
study the genetics of pediatric SLE (or syndromic or family) and to search for mutations in the known genetic lupus or new genes in collaboration with Professor Yanick Crow.
study the lymphocyte subpopulations and serum cytokines in pediatric patients with SLE (or syndromic or family) in the large Rhône- Alpes- Auvergne area.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Systemic Lupus Erythematosus (SLE)
Keywords
Systemic lupus erythematosus, genetic, immunological, pediatric, mutation, lupus
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
271 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Blood sampling
Arm Type
Experimental
Intervention Type
Genetic
Intervention Name(s)
Blood sampling
Intervention Description
Immunologic and genetic analysis from a single blood sample.
Primary Outcome Measure Information:
Title
New genes identification
Description
Description: Identification of genetic mutations in the following genes: TREX1, SAMHD1, ACP5, DNAse1, DNAse1L3, or in new lupus genes.
Time Frame
Once. At inclusion.
Secondary Outcome Measure Information:
Title
Immunological genotype and clinical abnormalities correlation
Description
Correlate genotype to immunological (interferon alpha, …) and clinical abnormalities (microcrania, growth retardation, …)
Time Frame
Once. At inclusion
Other Pre-specified Outcome Measures:
Title
Immunological component
Description
Identification of specific immunological factors of pediatric patients with SLE (or syndromic or family)
Time Frame
Once. At inclusion
Title
Characterization of sub-groups: size, articular manifestations (SLEDAI), hematology (hemoglobin, platelets, G White, ANA, ds-DNA, C3, C4, CH50, creatinine, proteinuria.
Time Frame
Once. At inclusion
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Male or female subject, major or minor of any age with SLE (defined according to the ACR criteria)
Onset pediatric (<18 years) OR
Syndromic Lupus (associated with growth retardation, neurological deficit not related to lupus, frostbite, lymphoproliferation, the kidney malformations, heart, lung, brain calcifications) OR
Lupus in context with familial consanguinity OR
Familial cases (2 cases of SLE related first degree relative) OR related topic of the first degree to a lupus patient participant (if family lupus or related parents) OR
mother/father's lupus patient (in cas of simplex lupus)
A person or beneficiary entitled to a social security scheme or similar
Informed consent signed by the person (or parent / holding parental authority for minors)
Exclusion Criteria:
- none
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexandre Belot, Dr
Organizational Affiliation
Hospices Civils de Lyon
Official's Role
Study Director
Facility Information:
Facility Name
Service d'hématologie / oncologie pédiatrique - CHU
City
Angers
Country
France
Facility Name
Néphrologie Pédiatrique - CHU Besançon
City
Besançon
Country
France
Facility Name
Hôpital Femme Mère Enfant
City
Bron
Country
France
Facility Name
Service de Néphrologie Pédiatrique
City
Clermont Ferrand
Country
France
Facility Name
Service de pédiatrie - CHU Fort de France
City
Fort De France
Country
France
Facility Name
Service de Néphrologie et Rhumatologie Pédiatrique
City
Grenoble
Country
France
Facility Name
Service de Rhumatologie Pédiatrique - Hôpital de Bicêtre
City
Le Kremlin Bicêtre
Country
France
Facility Name
Service de médecine interne - Centre de référence des maladies rares
City
Lille
Country
France
Facility Name
Service de néphrologie, endocrinologie, maladie métabolique et hématologie bénigne pédiatriques - Hôpital Jeanne de Flandre
City
Lille
Country
France
Facility Name
édiatrie générale, urgences et maladies infectieuses, Hôpital Salengro
City
Lille
Country
France
Facility Name
Service de Néphrologie - Hôpital Edouard Herriot
City
Lyon
Country
France
Facility Name
Centre de néphrologie et de transplantation rénale - Hôpital de la conception
City
Marseille
Country
France
Facility Name
Service de médecine infantile- Hôpital Nord
City
Marseille
Country
France
Facility Name
Service de médecine interne - Hôpitaux privés de Metz
City
Metz
Country
France
Facility Name
ervice d'urgence et post-urgences pédiatriques - CHU Arnaud de Villeneuve
City
Montpellier
Country
France
Facility Name
Service médecine infantile 2
City
Nancy
Country
France
Facility Name
Service de néphrologie pédiatrique - CHU de Nantes
City
Nantes
Country
France
Facility Name
Service d'immunologie et rhumatologie pédiatrique - Centre de référence de maladies rhumatologiques et inflammatoires rares en pédiatrie-Hôpital Necker-Enfants malades
City
Paris
Country
France
Facility Name
Service de médecine interne - Hôpital Saint Antoine
City
Paris
Country
France
Facility Name
Service de pédiatrie générale - Hôpital Robert-Debré
City
Paris
Country
France
Facility Name
Médecine Interne Adulte - Centre Hospitalier Lyon Sud
City
Pierre-Bénite
ZIP/Postal Code
69495
Country
France
Facility Name
Service de Rhumatologie - Centre Hospitalier Lyon Sud
City
Pierre-Bénite
Country
France
Facility Name
Service pédiatrie grands enfants-adolescents - CHU Hôpital Sud
City
Rennes
Country
France
Facility Name
Hôpital Nord
City
Saint Etienne
Country
France
Facility Name
Service de Pédiatrie Générale - CHU Réunion
City
Saint Pierre
Country
France
Facility Name
Service de néphrologie - médecine interne - Hypertension pédiatrique - Hôpital des enfants
City
Toulouse
Country
France
12. IPD Sharing Statement
Citations:
PubMed Identifier
28039062
Citation
Weill O, Decramer S, Malcus C, Kassai B, Rouvet I, Ginhoux T, Crow YJ, Rieux-Laucat F, Soulas-Sprauel P, Pagnier A, Kone-Paut I, Piram M, Galeotti C, Samaille C, Reumaux H, Lanteri A, Dubois SM, Lefebvre H, Burtey S, Maurier F, Carbasse A, Lemelle I, Meinzer U, Despert V, Flodrops H, Fabien N, Ranchin B, Hachulla E, Bader-Meunier B, Belot A. Familial and syndromic lupus share the same phenotype as other early-onset forms of lupus. Joint Bone Spine. 2017 Oct;84(5):589-593. doi: 10.1016/j.jbspin.2016.12.008. Epub 2016 Dec 28.
Results Reference
derived
Learn more about this trial
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
We'll reach out to this number within 24 hrs